Dr Jodie Schildkraut
Radboudumc
Nijmegen, the Netherlands
Dr. Laura Paramo MD
Ludwig Maximilian University Munich, Germany
Staggered dosing of rifampicin using to minimise tolerability problems and maximize efficacy
PanACEA team together with collaborators at Uppsala University recently published a model-based study further elucidating how to optimally dose rifampicin. The work suggest that a staggered approach, starting a bit lower and then increasing doses, may improve the tolerability for patients and thereby enable the higher doses which we demonstrated earlier is beneficial in terms…
SUDOCU headline results presented at CROI
On Tuesday 20 February 2023 our PanACEA colleague Dr Norbert Heinrich presented the headline-results from the PanACEA SUDOCU study at the 30th Conference on Retroviruses and Opportunistic Infections (CROI) in Seattle – the largest and most important conference on HIV and related conditions such as tuberculosis. SUDOCU investigated safety and efficacy of varying doses of…
Ivan Noreña MD, MSc.
Ludwig Maximilians University
Munich, Germany
PanACEA & SimpliciTB Annual Meeting, Mangochi, Malawi, 20th-22nd September 2022
Finally, after 2 years due to COVID-19, the PanACEA and SimpliciTB family were reunited in Malawi, hosted by Dr Marriott Nliwasa, Kamuzu University of Health Sciences at Makokola Retreat, Mangochi. The hospitality and organisation of all of the teams made it a very successful and enjoyable meeting. PanACEA The first day started with a variety…
Read more PanACEA & SimpliciTB Annual Meeting, Mangochi, Malawi, 20th-22nd September 2022
Dr med vet Andrea Kelly
Ludwig Maximilian University
Munich, Germany
Johann de Bruyn
TASK
Cape Town, South Africa
Hamza Hbil
Radboudumc
Nijmegen, the Netherlands
Dr. Bayode Romeo ADEGBITE
Centre de Recherches Médicales de Lamabaréné (CERMEL)
Gabon